Shaping the Research Agenda

PLoS Neglected Tropical Diseases

Volumn 9, Issue 1, 2015, Pages

  Certain, Edith ^a   Terry, Robert F ^a   Zicker, Fabio ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ANOPHELES GAMBIAE; ARTICLE; BOTTLENECK POPULATION; COMMUNITY CARE; DEVELOPING COUNTRY; ENDEMIC DISEASE; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MEDICAL EDUCATION; MEDICAL RESEARCH; NONHUMAN; ONCHOCERCIASIS; POLICY; POVERTY; PUBLIC HEALTH; SCIENTIST; TROPICAL DISEASE; VISCERAL LEISHMANIASIS; WORLD HEALTH ORGANIZATION;

EID: 84922238943     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003350     Document Type: Article

References (28)

1. Hotez P, Fenwick A, Savioli L, Molyneux DH, (2009) Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373: 1570–1575.
2. Molyneux DH (2014) Neglected tropical diseases: now more than just ‘other diseases’ – the post 2015 agenda. Int Health 1–9 doi:10. 1093/inthealth/ihu037.
3. The parasitic and bacterial infections known as the NTDs include three soil-transmitted helminth infections (ascariasis, hookworm infection, and trichuriasis), lymphatic filariasis, onchocerciasis, dracunculiasis, schistosomiasis, Chagas disease, human African trypanosomiasis, leishmaniasis, Buruli ulcer, leprosy, and trachoma. World Health Organization Fact sheets: Available: [http://www.who.int/topics/tropical_diseases/factsheets/neglected/en], accessed: 9 September 2014.
4. World Health Organization, Geneva (2012) Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination. Available: [http://www.who.int/phi/CEWG_Report_5_April_2012.pdf], accessed: 9 September 2014
5. Rand (2001) Science and Technology Collaboration: Building Capacity in developing Countries. MR-1357.0WB.RAND, Santa Monica.
6. World Health Organization/TDR (2008) Making a difference: 30 years of research and capacity building in tropical diseases. Available: [http://apps.who.int/iris/bitstream/10665/43689/1/9789241595575_eng.pdf?ua=1], accessed: 9 September 2014.
7. Technical Report of the TDR Disease Reference Group on Chagas Disease, Human African Trypanosomiasis and Leishmaniasis (2012) Available: [http://www.who.int/tdr/publications/research_priorities/en], accessed: 9 September 2014.
8. Technical Report of the TDR Disease Reference Group on helminth infections (2012) Available: [http://www.who.int/tdr/publications/helminth_infections/en], accessed: 9 September 2014.
9. Technical Report of the TDR Disease Reference Group on Zoonoses and Marginalized Infections (2012) Available: [http://www.who.int/tdr/publications/zoonoses/en], accessed 9 September 2014.
10. A report of the TDR Disease reference group on TB, leprosy and Buruli ulcer (2013) Available: [http://www.who.int/tdr/publications/tuberculosis_research/en], accessed: 9 September 2014.
11. Technical Report of the TDR Disease Reference Group on Environment, Agriculture and Infectious Diseases of Poverty (2013) Research Priorities for the environment, agriculture and infectious diseases of poverty. Available: [http://www.who.int/tdr/publications/environment/en], accessed: 9 September 2014.
12. TDR: a time to live or die ? (2012) Lancet, Volume 379 , Issue 9826, Page 1562. doi:10.1016/S0140-6736(12)60657-6.
13. TDR: Making a difference: Strategic plan 2012–2017. Available: [http://www.who.int/tdr/publications/strategic_plan/en], accessed: 9 September 2014.
14. Ridley RG, Fletcher ER Making a difference: 30 years of TDR (2008) Nature Reviews: Microbiology. 6: 401–407 doi:10.1038/nrmicro1899
15. The Trypanosomatid Genomes (2005) Science special edition. Available: [http://www.sciencemag.org/site/feature/misc/webfeat/tryp/], accessed: 9 September 2014.
16. Holt RA, Subramanian GM, Halpern A, Sutton GG, Charlab R, et al. (2002) The genome sequence of the malaria mosquito Anopheles gambiae. Science. 298(5591): 129–49 doi:10.1126/science.1076181
17. Genome Sequence of the Tsetse Fly (Glossina morsitans): Vector of African Trypanosomiasis International Glossina Genome Initiative (2014) Science Vol. 344 no. 6182 pp. 380–386. doi: 10.1126/science.1249656.
18. Berriman M, Haas BJ, LoVerde, PT, Wilson RA, Dillon GP, Cerqueira GC, et al. The Genome of the blood fluke Schistosoma mansoni. Nature: 2009-01-01; 460(); 352–358 doi:10.1038/nature08160.
19. H3ABioNet: A Sustainable African Bioinformatics Network for H3Africa. Available at: [http://h3africa.org/consortium/projects/16-projects/64-h3abionet-a-sustainable-african-bioinformatics-network-for-h3africa], accessed: 9 September 2014.
20. Macer D (2003) Ethical, legal and social issues of genetically modified disease vectors in public health. Social, Economic and Behavioural Research. Special Topics No. 1. World Health Organization/TDR. Available: [http://www.who.int/tdr/publications/tdr-research-publications/seb_topic1/en], accessed: 9 September 2014.
21. Integrated community-based interventions (2009) Annual Report, World Health Organization/TDR. Available: [http://whqlibdoc.who.int/hq/2010/TDR_BL11.10_eng.pdf?ua=1], accessed: 9 September 2014.
22. Teckle AH, Elhassan E, Isiyaku S, Amazigo UV, Bush S, et al. (2012) Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors. 2012 Feb 7 5: 28 doi:10.1186/1756-3305-5-28
23. Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, et al. (2012) Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PloS Negl Trop Dis. 6(9): e1825 doi:10.1371/journal.pntd.0001825
24. Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, et al. (2011) Visceral leishmaniasis: elimination with existing interventions. Lancet Infec Dis 11: : 322–325. doi: 10.1016/S1473-3099(10)70320-0
25. Resolution of the 66th World Health Assembly Follow up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination, page 48 WHA66.22. Available: [http://apps.who.int/gb/ebwha/pdf_files/WHA66-REC1/A66_REC1-en.pdf], accessed: 9 September 2014.
26. G-Finder – Global Funding of Innovation for Neglected Diseases Available: [https://g-finder.policycures.org/gfinder_report/], accessed: 9 September 2014.
27. Terry RF, Salm Jr JF, Nannei C, Dye C (2014) Creating a global observatory for health R&D Science 12 September Vol. 345 no. 6202 pp. 1302–1304 doi: 10.1126/science.1258737
28. Decision point of the 67th World Health Assembly Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination page 8, A67 Div3. Available: [http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_DIV3-en.pdf], accessed: 9 September 2014.